Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome

Eric Konofal; Isabelle Arnulf; Michel Lecendreux; Marie-Christine Mouren

doi:10.1016/j.pediatrneurol.2004.11.007

Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome

Pediatr Neurol. 2005 May;32(5):350-1. doi: 10.1016/j.pediatrneurol.2004.11.007.

Authors

Eric Konofal¹, Isabelle Arnulf, Michel Lecendreux, Marie-Christine Mouren

Affiliation

¹ Service de Psychopathologie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Paris, France.

PMID: 15866437
DOI: 10.1016/j.pediatrneurol.2004.11.007

Abstract

A 6-year-old male being treated with limited efficacy by methylphenidate immediate release for attention-deficit hyperactivity disorder also presented with sleep disruption due to potential restless legs/periodic limb movement syndrome. Treatment with the dopamine agonist ropinirole resulted in a significant improvement in both his attention-deficit hyperactivity disorder symptoms and sleep problems.

Publication types

Case Reports

MeSH terms

Attention Deficit Disorder with Hyperactivity / complications
Attention Deficit Disorder with Hyperactivity / drug therapy*
Child
Dopamine Agonists / administration & dosage*
Humans
Indoles / administration & dosage*
Male
Restless Legs Syndrome / complications
Restless Legs Syndrome / drug therapy*

Substances

Dopamine Agonists
Indoles
ropinirole